Contrive Datum Insights_Logo.jpg
Hepatitis B Vaccine Market Is Expected To Reach around USD 10.62 Billion by 2030, Grow at a CAGR Of 4.5% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
February 10, 2023 15:38 ET | Contrive Datum Insights Pvt Ltd
Farmington, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The Hepatitis B Vaccine Market Size Was Valued At USD 7.53 Billion In 2021. The Market Is Projected To Grow From USD 7.80 Billion In 2022 To USD 10.62...